Division of Laboratory Sciences, Centers for Disease Control and Prevention, Atlanta, GA, USA.
J Acquir Immune Defic Syndr. 2011 Dec 15;58(5):482-8. doi: 10.1097/QAI.0b013e318230dd77.
The Performance Evaluation Program for HIV-1 incidence tests provided quality assurance services to laboratories conducting the serological testing algorithm for recent HIV seroconversion by use of a modified less-sensitive version of the Vironostika HIV-1 MicroElisa System assay. We report on the performance of the assay using proficiency testing and quality control materials tested from 2001 to 2008.
Two sets of 5 blinded serum panels using common calibration and quality control materials were tested. The mean, standard deviation, and coefficient of variation were calculated. Results were analyzed for misclassifications: false recent HIV infection errors (long-term infection classified as HIV infection less than 1 year), false long-term infection errors (HIV infection less than 1 year classified as long-term infection), and differences in standardized optical density means and variances over time.
The false recent error rate was 1.26% (n = 2219). The false long-term error rate was 0.25% (n = 1618). No significant trends were observed for misclassification rates by year, and no significant trend in the standardized optical density over 7 years was observed.
Laboratories using the less-sensitive Vironostika HIV-1 assay produced consistent results by use of a common calibrator and quality control materials.
HIV-1 感染发生率检测的性能评估计划为使用 Vironostika HIV-1 MicroElisa 系统检测方法的改良低灵敏度版本进行近期 HIV 血清转化血清学检测的实验室提供了质量保证服务。我们报告了使用能力验证和质量控制材料在 2001 年至 2008 年进行检测的该检测方法的性能。
使用常见的校准和质量控制材料测试了两组 5 份盲血清板。计算平均值、标准差和变异系数。分析结果的错误分类:假近期 HIV 感染错误(长期感染归类为感染少于 1 年),假长期感染错误(少于 1 年的 HIV 感染归类为长期感染),以及标准化光密度均值和方差随时间的差异。
假近期错误率为 1.26%(n = 2219)。假长期错误率为 0.25%(n = 1618)。按年份观察不到错误分类率的显著趋势,并且在 7 年内标准化光密度也没有观察到显著趋势。
使用改良低灵敏度 Vironostika HIV-1 检测方法的实验室通过使用常见的校准品和质量控制材料产生了一致的结果。